American International Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,719
| Closed | -$121K | – | 375 |
|
|
2024
Q1 | $121K | Buy |
4,719
+2,059
| +77% | +$52.8K | ﹤0.01% | 2410 |
|
|
2023
Q4 | $73.4K | Sell |
2,660
-10
| -0.4% | -$610 | ﹤0.01% | 2708 |
|
|
2023
Q3 | $162K | Buy |
2,670
+94
| +4% | +$6.6K | ﹤0.01% | 2237 |
|
|
2023
Q2 | $169K | Buy |
2,576
+89
| +4% | +$6.51K | ﹤0.01% | 2272 |
|
|
2023
Q1 | $158K | Buy |
2,487
+523
| +27% | +$59.7K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $272K | Buy |
1,964
+131
| +7% | +$18.5K | ﹤0.01% | 1963 |
|
|
2022
Q3 | $232K | Buy |
1,833
+159
| +9% | +$18K | ﹤0.01% | 2072 |
|
|
2022
Q2 | $139K | Sell |
1,674
-3
| -0.2% | -$233 | ﹤0.01% | 2402 |
|
|
2022
Q1 | $163K | Sell |
1,677
-118
| -7% | -$15.6K | ﹤0.01% | 2366 |
|
|
2021
Q4 | $359K | Sell |
1,795
-1,059
| -37% | -$250K | ﹤0.01% | 2018 |
|
|
2021
Q3 | $706K | Sell |
2,854
-68
| -2% | -$19.4K | ﹤0.01% | 1634 |
|
|
2021
Q2 | $1.21K | Buy |
2,922
+2,837
| +3,338% | +$1.12M | ﹤0.01% | 1411 |
|
|
2021
Q1 | $33 | Sell |
85
-9
| -10% | -$4.43K | ﹤0.01% | 3069 |
|
|
2020
Q4 | $53 | Sell |
94
-2
| -2% | -$1.27K | ﹤0.01% | 2944 |
|
|
2020
Q3 | $67K | Sell |
96
-1
| -1% | -$780 | ﹤0.01% | 2744 |
|
|
2020
Q2 | $77K | Buy |
97
+28
| +41% | +$21.1K | ﹤0.01% | 2686 |
|
|
2020
Q1 | $41K | Buy |
69
+2
| +3% | +$1.95K | ﹤0.01% | 2762 |
|
|
2019
Q4 | $76K | Sell |
67
-2
| -3% | -$2.17K | ﹤0.01% | 2753 |
|
|
2019
Q3 | $82K | Hold |
69
| – | – | ﹤0.01% | 2714 |
|
|
2019
Q2 | $113K | Sell |
69
-20
| -22% | -$34.6K | ﹤0.01% | 2609 |
|
|
2019
Q1 | $181K | Sell |
89
-3
| -3% | -$5.28K | ﹤0.01% | 2262 |
|
|
2018
Q4 | $118K | Hold |
92
| – | – | ﹤0.01% | 2503 |
|
|
2018
Q3 | $174K | Buy |
92
+5
| +6% | +$10.3K | ﹤0.01% | 2519 |
|
|
2018
Q2 | $176K | Sell |
87
-2,328
| -96% | -$5.31M | ﹤0.01% | 2432 |
|
|
2018
Q1 | $5.34M | Sell |
2,415
-130
| -5% | -$331K | 0.02% | 700 |
|
|
2017
Q4 | $5.87M | Buy |
2,545
+223
| +10% | +$453K | 0.02% | 687 |
|
|
2017
Q3 | $4.13M | Buy |
2,322
+358
| +18% | +$500K | 0.01% | 769 |
|
|
2017
Q2 | $2.67M | Buy |
1,964
+61
| +3% | +$73.6K | 0.01% | 888 |
|
|
2017
Q1 | $2.24M | Buy |
1,903
+258
| +16% | +$263K | 0.01% | 915 |
|
|
2016
Q4 | $1.31M | Sell |
1,645
-4
| -0.2% | -$3.18K | 0.01% | 1090 |
|
|
2016
Q3 | $1.45M | Buy |
1,649
+2
| +0.1% | +$1.45K | 0.01% | 1025 |
|
|
2016
Q2 | $923K | Buy |
1,647
+1,532
| +1,332% | +$868K | ﹤0.01% | 1230 |
|
|
2016
Q1 | $64K | Sell |
115
-484
| -81% | -$297K | ﹤0.01% | 3727 |
|
|
2015
Q4 | $498K | Buy |
599
+384
| +179% | +$384K | ﹤0.01% | 2041 |
|
|
2015
Q3 | $239K | Buy |
215
+16
| +8% | +$29.2K | ﹤0.01% | 2649 |
|
|
2015
Q2 | $435K | Sell |
199
-1,003
| -83% | -$2.04M | ﹤0.01% | 2308 |
|
|
2015
Q1 | $1.88M | Buy |
1,202
+11
| +0.9% | +$14.5K | 0.01% | 1203 |
|
|
2014
Q4 | $1.41M | Buy |
1,191
+98
| +9% | +$65.5K | 0.01% | 1317 |
|
|
2014
Q3 | $508K | Buy |
1,093
+130
| +13% | +$60K | ﹤0.01% | 2132 |
|
|
2014
Q2 | $481K | Buy |
963
+604
| +168% | +$194K | ﹤0.01% | 2211 |
|
|
2014
Q1 | $106K | Buy |
359
+9
| +3% | +$2.73K | ﹤0.01% | 3397 |
|
|
2013
Q4 | $95.1K | Buy |
+350
| New | +$97.8K | ﹤0.01% | 3370 |
|
Other funds holding BLUE
PAI
American International Group's BLUE Position: Q2 2024 in Review
American International Group sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 4,719 shares — an estimated $121K sold.
American International Group first reported a position in BLUE in Q4 2013 and held it in 42 quarters. The position peaked at $5.87M in Q4 2017. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.
- American International Group reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
- American International Group sold 4,719 bluebird bio shares in Q2 2024, an estimated $121K.
- American International Group first reported a position in bluebird bio in Q4 2013 and held it in 42 quarters.
- American International Group's bluebird bio position peaked at $5.87M in Q4 2017.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.